Argent Biopharma (AU:RGT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent Biopharma Limited has announced the issuance of 4 million new fully paid ordinary shares following approval at the company’s general meeting on October 1, 2024. These shares are now set to be quoted on the ASX under the ticker code RGT, as of October 15, 2024. This move marks a newsworthy development for investors tracking the biopharmaceutical sector.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.